CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
10.20
+0.10 (0.99%)
At close: Oct 7, 2025, 4:00 PM EDT
10.20
0.00 (0.00%)
After-hours: Oct 7, 2025, 4:10 PM EDT
CEL-SCI Market Cap
CEL-SCI has a market cap or net worth of $82.33 million as of October 7, 2025. Its market cap has increased by 21.79% in one year.
Market Cap
82.33M
Enterprise Value
88.26M
1-Year Change
21.79%
Ranking
Category
Stock Price
$10.20
Market Cap Chart
Since December 1, 1998, CEL-SCI's market cap has increased from $27.40M to $82.33M, an increase of 200.48%. That is a compound annual growth rate of 4.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 6, 2025 | 69.50M | 182.52% |
Dec 31, 2024 | 24.60M | -81.90% |
Dec 29, 2023 | 135.90M | 32.46% |
Dec 30, 2022 | 102.60M | -66.58% |
Dec 31, 2021 | 307.00M | -33.78% |
Dec 31, 2020 | 463.60M | 43.22% |
Dec 31, 2019 | 323.70M | 297.18% |
Dec 31, 2018 | 81.50M | 226.00% |
Dec 29, 2017 | 25.00M | 96.85% |
Dec 30, 2016 | 12.70M | -73.60% |
Dec 31, 2015 | 48.10M | -9.42% |
Dec 31, 2014 | 53.10M | 80.61% |
Dec 31, 2013 | 29.40M | -60.16% |
Dec 31, 2012 | 73.80M | 10.81% |
Dec 30, 2011 | 66.60M | -60.45% |
Dec 31, 2010 | 168.40M | 25.11% |
Dec 31, 2009 | 134.60M | 300.60% |
Dec 31, 2008 | 33.60M | -42.37% |
Dec 31, 2007 | 58.30M | 27.85% |
Dec 29, 2006 | 45.60M | 25.27% |
Dec 30, 2005 | 36.40M | -15.74% |
Dec 31, 2004 | 43.20M | -37.39% |
Dec 31, 2003 | 69.00M | 845.21% |
Dec 31, 2002 | 7.30M | -67.12% |
Dec 31, 2001 | 22.20M | -27.69% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 753.98B |
Johnson & Johnson | 454.31B |
AbbVie | 413.22B |
UnitedHealth Group | 326.22B |
Novo Nordisk | 264.73B |
AstraZeneca | 264.35B |
Novartis AG | 256.18B |
Abbott Laboratories | 234.25B |